Crinetics - Developing Therapies For Endocrine Diseases
5AM Ventures
Description: The power to stop cancer. The experience to know how. The dedication to make a difference.
toggle menu Menu The power to stop cancer. The experience to know how. The dedication to make a difference. more Careers See our open positions News Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer Our purpose We are bringing the power of precision radiopharmaceuticals into a new era. Radiopharmaceuticals – a class of precision oncology medicines – are poised to transform the treatment of solid tumors. By hitching a radioisotope to a small molecule, these potent therapies can selec
We are applying our deep drug discovery and development expertise against novel cancer targets from a broad class of surface receptors to produce targeted small molecule radiopharmaceuticals. We seek to create effective new treatments for cancer patients that enable us to go far beyond what’s been done before – bringing us closer to the day we can say “cure.”
The versatile utility of radiopharmaceuticals is core to our development strategy. Part of a treatment strategy known as theragnostics, radiopharmaceuticals can be used for both therapy and diagnosis.
Crinetics - Developing Therapies For Endocrine Diseases
5AM Ventures